Association between corpus luteum volume and the success of termination of pregnancy with mifepristone

Abstract Background: Mifepristone is a progesterone antagonist often used in medical termination of pregnancy. One of its targets is the corpus luteum, the main source of progesterone in initial pregnancy maintenance. Corpus luteum volume is related to serum progesterone levels. Objective: This study intended to evaluate whether there is an association between corpus luteum volume and the success rate of pharmacological termination of pregnancy with mifepristone and misoprostol. Methods: This was a prospective, longitudinal, observational study. 176 women deciding to terminate their pregnancy were included. At the first medical visit we confirmed the presence of a viable pregnancy with less than 10 weeks and estimated corpus luteum volume by transvaginal ultrasound. Medical termination of pregnancy protocol in our hospital consisted of oral mifepristone 200 mg followed (24 hours) by oral misoprostol 200 µg one pill every hour until a maximum of eight doses. At the reevaluation visit, we registered clinical data and confirmed the success of the procedure by vaginal ultrasound. Results: The success rate of medical termination of pregnancy was 95.5%. No differences regarding corpus luteum volume were observed between successful and unsuccessful termination of pregnancy groups. Conclusion: In our sample there was no association between corpus luteum volume and the success rate of medical termination of pregnancy.

Saved in:
Bibliographic Details
Main Authors: Rego,Susana, Reis-de-Carvalho,Catarina, Neves,Joaquim, Carvalho,Rui
Format: Digital revista
Language:English
Published: Euromédice, Edições Médicas Lda. 2022
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000400327
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1646-58302022000400327
record_format ojs
spelling oai:scielo:S1646-583020220004003272023-03-06Association between corpus luteum volume and the success of termination of pregnancy with mifepristoneRego,SusanaReis-de-Carvalho,CatarinaNeves,JoaquimCarvalho,Rui Corpus luteum Medical termination of pregnancy Mifepristone Progesterone Ultrasound Abstract Background: Mifepristone is a progesterone antagonist often used in medical termination of pregnancy. One of its targets is the corpus luteum, the main source of progesterone in initial pregnancy maintenance. Corpus luteum volume is related to serum progesterone levels. Objective: This study intended to evaluate whether there is an association between corpus luteum volume and the success rate of pharmacological termination of pregnancy with mifepristone and misoprostol. Methods: This was a prospective, longitudinal, observational study. 176 women deciding to terminate their pregnancy were included. At the first medical visit we confirmed the presence of a viable pregnancy with less than 10 weeks and estimated corpus luteum volume by transvaginal ultrasound. Medical termination of pregnancy protocol in our hospital consisted of oral mifepristone 200 mg followed (24 hours) by oral misoprostol 200 µg one pill every hour until a maximum of eight doses. At the reevaluation visit, we registered clinical data and confirmed the success of the procedure by vaginal ultrasound. Results: The success rate of medical termination of pregnancy was 95.5%. No differences regarding corpus luteum volume were observed between successful and unsuccessful termination of pregnancy groups. Conclusion: In our sample there was no association between corpus luteum volume and the success rate of medical termination of pregnancy.info:eu-repo/semantics/openAccessEuromédice, Edições Médicas Lda.Acta Obstétrica e Ginecológica Portuguesa v.16 n.4 20222022-12-01info:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000400327en
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Rego,Susana
Reis-de-Carvalho,Catarina
Neves,Joaquim
Carvalho,Rui
spellingShingle Rego,Susana
Reis-de-Carvalho,Catarina
Neves,Joaquim
Carvalho,Rui
Association between corpus luteum volume and the success of termination of pregnancy with mifepristone
author_facet Rego,Susana
Reis-de-Carvalho,Catarina
Neves,Joaquim
Carvalho,Rui
author_sort Rego,Susana
title Association between corpus luteum volume and the success of termination of pregnancy with mifepristone
title_short Association between corpus luteum volume and the success of termination of pregnancy with mifepristone
title_full Association between corpus luteum volume and the success of termination of pregnancy with mifepristone
title_fullStr Association between corpus luteum volume and the success of termination of pregnancy with mifepristone
title_full_unstemmed Association between corpus luteum volume and the success of termination of pregnancy with mifepristone
title_sort association between corpus luteum volume and the success of termination of pregnancy with mifepristone
description Abstract Background: Mifepristone is a progesterone antagonist often used in medical termination of pregnancy. One of its targets is the corpus luteum, the main source of progesterone in initial pregnancy maintenance. Corpus luteum volume is related to serum progesterone levels. Objective: This study intended to evaluate whether there is an association between corpus luteum volume and the success rate of pharmacological termination of pregnancy with mifepristone and misoprostol. Methods: This was a prospective, longitudinal, observational study. 176 women deciding to terminate their pregnancy were included. At the first medical visit we confirmed the presence of a viable pregnancy with less than 10 weeks and estimated corpus luteum volume by transvaginal ultrasound. Medical termination of pregnancy protocol in our hospital consisted of oral mifepristone 200 mg followed (24 hours) by oral misoprostol 200 µg one pill every hour until a maximum of eight doses. At the reevaluation visit, we registered clinical data and confirmed the success of the procedure by vaginal ultrasound. Results: The success rate of medical termination of pregnancy was 95.5%. No differences regarding corpus luteum volume were observed between successful and unsuccessful termination of pregnancy groups. Conclusion: In our sample there was no association between corpus luteum volume and the success rate of medical termination of pregnancy.
publisher Euromédice, Edições Médicas Lda.
publishDate 2022
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000400327
work_keys_str_mv AT regosusana associationbetweencorpusluteumvolumeandthesuccessofterminationofpregnancywithmifepristone
AT reisdecarvalhocatarina associationbetweencorpusluteumvolumeandthesuccessofterminationofpregnancywithmifepristone
AT nevesjoaquim associationbetweencorpusluteumvolumeandthesuccessofterminationofpregnancywithmifepristone
AT carvalhorui associationbetweencorpusluteumvolumeandthesuccessofterminationofpregnancywithmifepristone
_version_ 1762929149696016384